Stock screener

CUE

Conviction 84HealthcareScan · Mon, Jul 20, 2026
Bearish harami
CUE$30.64-1.67%
ResistanceSupportVol 14Insider buy
63 bars
2
Vol MA14 152.11K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Cue Biopharma, Inc.PHARMACEUTICAL PREPARATIONSwww.cuebiopharma.com
Price30.64
Change-1.67%
Gap-0.10%
Rel volume1.20×
Avg volume133.39K
Avg $ vol4.19M
SMA 2030.40
SMA 5027.77
SMA 2008.29
Price vs 50+10.35%
Price vs 200+269.41%
MA stackbullish
50/200 cross
Supertrendup · 26.90
RSI (14)52
MACD hist-0.51
MACD crossbear · 3d
Stoch %K / %D25 / 23
ADX (14)35
+DI / −DI34 / 19
RSI divergence
MACD divergence
ATR %+13.83%
ADR %13.99%
52w high36.78
52w low0.1770
From 52w high-16.69%
Above 52w low+17210.73%
New 52w highNo
SqueezeOff
Bollinger width43.50%
%B0.52
Donchian pos28.90%
Donchian high45.50
Donchian low24.60
AVWAP (52w high)32.31
vs AVWAP high-5.17%
AVWAP (52w low)2.17
vs AVWAP low+1312.44%
OBV trendUp
Chaikin MF (20)-0.07
Today vs 20d1.20×
Avg vol (14d)152.11K
Avg vol (20d)133.39K
Avg $ vol (20d)4.19M
Market cap123.96M
RS 3m (vs SPY)+4959.09%
RS 6m (vs SPY)+9030.16%
RS line new highNo
Trend template8/8
Technical rank94.1
1 week-0.91%
1 month+14.63%
3 months+4954.44%
6 months+10961.37%
1 year+3547.62%
YTD+8981.21%
P/E-4.66
P/B5.74
P/S4.51
P/FCF-5.67
EPS-0.2800
Div yield
ROE-123.11%
ROA-86.15%
Debt/Eq0.19
Current3.57
EV/EBITDA-4.36
Gross margin
Net margin-96.85%
Rev growth195.75%
EPS growth34.60%
Price target
Target upside
Analyst rating
Institutional
Ent. value111.58M
Revenue5.69M
Net income-5.18M
Gross profit
Free cash flow-21.86M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out4.2M
Employees29
ListedTue, Jan 2, 2018
Free float94.71M
Float %97.2%
Short interest298.08K
Days to cover2.7d
Short volume58.2%
Squeeze score29 / 100
Next earnings
EPS forecast
Last EPS vs est
Last surprise
Setup gradeA
Conviction84 / 100
Pattern quality
Tech rank94.1 / 100
Group rank23 / 100
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBearish harami
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CUE

All disclosures →
No recent disclosed trades by Congress in CUE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CUE · 10 buys

InsiderSideShares
Borie Dominique Christian
Chief Medical Officer · Common Stock · 2026-07-13
Grant31.5K
Borie Dominique Christian
Chief Medical Officer · Stock Option (Right to Buy) · 2026-07-13
Grant63K
Camardo Daniel A.
Director · Common Stock · 2026-07-09
Grant21.8K
Ray Sumita
Chief Legal Compliance Officer · Common Stock · 2026-07-09
Grant54.59K
Ray Sumita
Chief Legal Compliance Officer · Common Stock · 2026-07-09
Grant54.59K
Lin Shao-Lee
Chief Executive Officer · Common Stock · 2026-07-09
Grant327.54K
Lin Shao-Lee
Chief Executive Officer · Common Stock · 2026-07-09
Grant327.54K
Garzone Pamela
Director · Common Stock · 2026-07-09
Grant21.8K
Sarraf Pasha
Director · Common Stock · 2026-07-09
Grant21.8K
Meehan Viola Mong
Director · Common Stock · 2026-07-09
Grant21.8K

SEC filings

EDGAR filings in CUE · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.